Dynavax Technologies Corporation

(NASDAQ:DVAX)
  Jun 30, 2008 Mar 31, 2008 Dec 31, 2007 Sep 30, 2007
Operating revenue
Total Revenue 9,978 6,314 9,295 1,014
Operating Revenue 9,978 6,314 9,295 1,014
Adjustments To Revenue — — — —
Cost Of Sales -801 -107 1,464 -380
Cost Of Sales With Depreciation — — — —
Gross Operating Profit 10,779 6,421 7,831 1,394
Operating Expenses
Research And Development Expenses 12,946 15,120 18,183 14,909
Selling General And Administrative Expenses 3,420 4,571 4,879 5,029
Advertising Expenses — — — —
Operating Income Before Depreciation -5,587 -13,270 -15,231 -18,544
Operating Income -6,633 -13,622 -14,017 -19,175
Depreciation 1,046 352 -1,214 631
Depreciation Unreconciled — — — —
Amortization — — — —
Amortization Of Intangibles 245 245 250 251
Operating Income After Depreciation -6,633 -13,622 -14,017 -19,175
Non Operating Expenses
Interest Expense 1,340 1,344 1,719 —
Pre Tax Income -7,568 -13,995 -14,077 -18,722
Income Taxes — — — —
Minority Interest -1,489 -1,566 -2,001 -1,621
Income Before Income Taxes — — — —
Net Income From Continuing Operations -6,079 -12,429 -12,076 -17,101
Net Income From Discontinued Operations — — — —
Net Income From Total Operations -6,079 -12,429 -12,076 -17,101
Non Recurring Events
Extraordinary Income Losses — — — —
Income From Cummulated Effect Of Accounting Changes — — — —
Income From Tax Loss Carryforward — — — —
Other Gains And Losses — — — —
Total Net Income -6,079 -12,429 -12,076 -17,101
Normalized Income -6,079 -12,429 -12,076 -17,101
NetIncome Available For Common -6,079 -12,429 -12,076 -17,101
Preferred Dividends — — — —
Excise Taxes — — — —